Tokio Marine Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Buy
5,316
+36
+0.7% +$10.9K 0.05% 289
2026
Q1
$1.75M Buy
5,280
+265
+5% +$90.2K 0.06% 245
2025
Q4
$1.99M Buy
5,015
+571
+13% +$253K 0.07% 216
2025
Q3
$2.03M Buy
+4,444
New +$1.81M 0.07% 214
2024
Q3
Sell
-3,973
Closed -$965K 565
2024
Q2
$965K Buy
3,973
+124
+3% +$19.6K 0.05% 278
2024
Q1
$575K Buy
3,849
+274
+8% +$45.7K 0.03% 397
2023
Q4
$684K Buy
3,575
+195
+6% +$33.2K 0.04% 324
2023
Q3
$599K Buy
3,380
+309
+10% +$59K 0.04% 320
2023
Q2
$583K Buy
3,071
+204
+7% +$40.4K 0.04% 326
2023
Q1
$574K Buy
2,867
+474
+20% +$99.6K 0.04% 308
2022
Q4
$569K Buy
2,393
+201
+9% +$42.9K 0.04% 281
2022
Q3
$439K Buy
2,192
+110
+5% +$21K 0.04% 300
2022
Q2
$304K Buy
2,082
+374
+22% +$53.1K 0.03% 371
2022
Q1
$279K Buy
1,708
+168
+11% +$25.6K 0.02% 394
2021
Q4
$261K Sell
1,540
-7
-0.5% -$1.3K 0.02% 420
2021
Q3
$292K Buy
1,547
+263
+20% +$49.3K 0.03% 346
2021
Q2
$218K Buy
+1,284
New +$188K 0.02% 407

Other funds holding ALNY

Tokio Marine Asset Management's ALNY Position: Q2 2026 in Review

Tokio Marine Asset Management increased its Alnylam Pharmaceuticals (ALNY) stake by 0.68% in Q2 2026, buying an estimated $10.9K and bringing the position to 5,316 shares worth $1.6M. The position accounts for 0.05% of the portfolio, ranked #289.

Tokio Marine Asset Management first reported a position in ALNY in Q2 2021 and has held it in 17 quarters since. The position peaked at $2.03M in Q3 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Tokio Marine Asset Management held 5,316 shares of Alnylam Pharmaceuticals worth $1.6M as of Q2 2026.
  • Tokio Marine Asset Management bought 36 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $10.9K.
  • Alnylam Pharmaceuticals made up 0.05% of Tokio Marine Asset Management's portfolio in Q2 2026, its #289 holding.
  • Tokio Marine Asset Management first reported a position in Alnylam Pharmaceuticals in Q2 2021 and has held it in 17 quarters since.
  • Tokio Marine Asset Management's Alnylam Pharmaceuticals position peaked at $2.03M in Q3 2025.
  • 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Tokio Marine Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.